We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 82.50 | 80.00 | 85.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -3.77 | 11M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/6/2020 20:12 | Without seeming unkind TO in just over 12 months will have raised over £7m through placings. Awarded himself and his team millions of options. Given Bleepa away to two NHS trusts. Seen the departure of Ganeshan. Put Texrad on the backburner. Has never put a penny of his own cash into the company. God I hope he knows what he is doing! LOL. GLA and goodnight, duc. | ducatiman | |
15/6/2020 20:05 | DC I agree with you, my average is 2.3p so I am down over 50% at mo. Can understand why they didn't go for govt loan as it's only 25% of turnover. Nevertheless, they now have over a billion shares, even at 10p it would value the company at £100m. Just does not feel like they can achieve that valuation currently. | sonie01 | |
15/6/2020 19:33 | I think the problem will be if some larger non-nhs organisations have said something along the lines of “add this that and the other and we’ve got a major distribution possibility for you”. I’ve been through that with a product years ago - its very tempting to spend money when some large corporate has sounded interested. Best advice we had was to ignore it and just get on with selling what we had. This is starting to feel to me just like all the other businesses that start heading towards international stuff before they’ve got a core profitable market | yump | |
15/6/2020 19:28 | Good luck guys.. Side. | sideshowbull | |
15/6/2020 18:55 | Sorry to hear that SSB but I do understand. Let's see what tomorrow brings. | lr2 | |
15/6/2020 18:38 | I am out, sorry friends. Much better places to put my money. BWTFDIK side | sideshowbull | |
15/6/2020 18:30 | Sounds about right Brasso. Raising £1-£2 million supports a "lifestyle". Raising over £5 million hints at something much more substantial. Hopefully Tom is reading these boards over the next day or two and putting together a video to answer our concerns. | lr2 | |
15/6/2020 18:24 | I think I will give this co’ 6 months to prove that they are not supporting a “lifestyleR | ducatiman | |
15/6/2020 18:22 | The placing document will almost certainly contain a lot more information. If anyone has access to it please can you post relevant info. I agree with Yump that it is worrying that Bleepa product is still being discussed as up for more development. What is in the market as of now is what you get for now. Lock down the product ASAP. Continual modifications will almost certainly result in a bit of a dog's dinner. The released product should stay as is except for the most urgent of changes. Collect a wish list from the users by all means but only promise the truly beneficial in the next release. Rookie mistake by the board if they don't. Listen to Future Processing development bods, listen to Antoine Saillant. Their knowledge is vital. Don't try to override what they tell you guys on the board. | lr2 | |
15/6/2020 16:44 | Needs some more detail on how many NHS Trusts are showing interest for me to stay in here longer term. Very easy to do the usual story-telling and get some institutional investors to put money in that is not theirs (startup high risk funds etc.). Much, much more difficult to get trials in say 10 trusts. Not a lot to ask on the face of it, but history is not on their side. £5mln is a lot, especially if Bleepa needs development. Its a common thing to reckon you've got a product to sell and then find that potential customers start asking for this that and the other. Development can take years. Bleepa appears now NOT to be an off-the-shelf sell. No news in the next months and I'll just take my investment elsewhere. I wish I could raise £5mln for something that hasn't actually sold at all yet. I want to see justification for the placing, in something other than fine words, to remain invested. | yump | |
15/6/2020 15:56 | A couple of things I found very interesting:- Product development to extend and develop the functionality of Bleepa®, including for non-healthcare applications Feedback CEO Tom Oakley said: “At this key moment for our company we are delighted to have generated the support of some of London’s leading institutional investors for our vision of Bleepa®. Tomorrows session should also be interesting. | ged5 | |
15/6/2020 12:49 | No, I didn't mean that. I said that Bleepa "will bring in 500 x £10 x 12 mths = £60k". Free at present. Feet under table. Start charging that sort of sum down the line. Should have put emphasis on WILL BRING IN. | lr2 | |
15/6/2020 12:41 | LR2 do you think they're paying £60k for Bleepa? one was a trial one was added to a Cadran upgrade. Ive not seen suggestion Feedback are earning £60k on those yet. | davydoo | |
15/6/2020 12:34 | Davy, re your post #5703, are you sure? Consider - Currently Bleepa sits in two health authorities and probably has no more than 500 or so users. Yearly that will bring in 500 x £10 x 12 mths = £60k. Certainly not enough to get a £5 mil plus placing off the ground. And here I assume it will get off the ground so they have sung a siren song to some interested parties. I think the song goes something like this. What if Feedback grab 5% of NHS usage a year down the line. The UK has 150,000 doctors and 320,000 nurses. Then they would have 23,500 x £10 x 12 = £2.82 million a year. And they talk about the rest of the world in the RNS. 10-15 mil doctors and nursing staff at NHS levels means another 21.3 - 32.0 mil users. Say they grab 0.5% world market share to start - 50,000 doctors and 106,500 nursing staff. 156,500 x £10 x 12 = £18.78 mil. That's £21.6 mil a year total. PE ratio of 20 for a teeny, weeny growth company maybe - £432 mil. Not a bad future scenario for a £10 mil company after placing. May not give you a price rise anytime soon, then again maybe it will. | lr2 | |
15/6/2020 10:40 | Another long wait. Wonder what the conditions of the placings are? No mention of warrants. Would be good to see BOD putting hands in collective pockets. | digger2779 | |
15/6/2020 10:00 | Just a few thoughts. Tom, if you're looking in please try to answer any questions in your next video chat. All told, I'm quietly pleased but a little nervous. 1. I'd like to get a look at the placing document. Can anyone oblige? Megan? 2. Not a huge discount for such a huge raise. Confident of take up? 3. Funds all going to Bleepa. Is a TexRAD sale on the cards? 4. Direct and indirect sales mentioned. Who are the likely partners? What do they bring to the party? 5. Extend functionality of Bleepa. Hmm, not sure about this. More info guys. Lots more. Don't forget to walk before you run. 6. Territory expansion. I should bloody well hope so. Start with Poland. 7. Placing and open offer not underwritten. How much are Stanford Capital getting? £310k? 8. Trying to tempt Venture Capital Trusts not a bad idea. Interested to see if they get a bite. 9. Bleepa from concept to certified medical device in less than 12 months. Amazing. Seen another company take 12 years for phone based app. 10. 10-15 million doctors worldwide. Wonder what percentage they hope to get. | lr2 | |
15/6/2020 09:30 | There’s not much to say here until they get Bleepa to wider audience now, they’ve ticked the boxes with existing clients, now they’ve got to get more hooks. The fundraiser was ok, if they do something other than feed certain snouts with it. Glad I’ve been trading some of these or I’d feel a bit frustrated. | riggerbeautz | |
15/6/2020 08:36 | No posts over the weekend that's why.. | lukehold | |
15/6/2020 08:36 | impressive fund raise but for me it kills the chance for substantial share price increases anytime soon. | davydoo | |
15/6/2020 08:36 | Agreed yump | sonie01 | |
15/6/2020 08:32 | Meanwhile... would hope that there are some feet firmly in doors with other trusts, to be raising this amount. Otherwise it will be stuck at 1p forever. Probably explains why there wasn’t much buying - these things are very leaky. | yump | |
15/6/2020 08:28 | Lukehold Complete lie from you, I have never mentioned cashflow. At least try and make a valid point you really are making yourself look really thick. Put you on filter just a waste of space and time. | yump |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions